FRANCE — Investors have demonstrated strong support for Mariana Oncology’s series B financing, with the round oversubscribed at a remarkable US$175 million. Notably, pharmaceutical giant Eli Lilly has joined this…
Read MoreDay: 8 September 2023
IVI, EuBiologics, and DEK forge partnership to boost oral cholera vaccine production in Ghana
GHANA — The International Vaccine Institute (IVI), EuBiologics, and DEK Vaccines Limited (DEK) have solidified their collaboration by signing a memorandum of understanding (MOU) aimed at amplifying the production of…
Read MoreAfrica CDC opens applications for African Epidemic Service Fellowship Program to boost public health
ETHIOPIA — In honor of World Field Epidemiology Day, the Africa Centres for Disease Control and Prevention (Africa CDC) has announced the initiation of applications for its esteemed African Epidemic…
Read MoreGSK & other corporate leaders urge EU to slash greenhouse gas emissions by 90% by 2040
UNITED KINGDOM — British pharma giant GSK, alongside other corporate leaders, Coca-Cola, Unilever, and other influential members of the Corporate Leaders Group (CLG) Europe is urging the European Union (EU)…
Read MoreGlaxoSmithKline (GSK) Nigeria to cease operations amidst challenges and market shifts
NIGERIA — GlaxoSmithKline (GSK) Nigeria has announced its decision to withdraw from the Nigerian market due to mounting challenges and a shifting business landscape, following a strategic move that parallels…
Read MoreKenya exceeds cholera vaccination target amidst ongoing outbreak
KENYA — Kenya has surpassed its goal of vaccinating 1.59 million individuals across eight high-risk counties during a 10-day oral cholera vaccine (OCV) campaign. The campaign, which ran from August…
Read MoreCleveland Clinic Abu Dhabi welcomes Hasan Jasem Al Nowais as the new Board Chair
UAE – Cleveland Clinic Abu Dhabi has tapped Hasan Jasem Al Nowais as the new Chairman of the hospital’s Board of Directors. Hasan Jasem Al Nowais is currently the Group…
Read MoreMoHAP greenlights Roche’s gene therapy for Duchenne Muscular Dystrophy in children
UAE – The Ministry of Health and Prevention (MoHAP) has granted accelerated approval of Roche’s gene therapy for the treatment of ambulatory children with Duchenne Muscular Dystrophy (DMD). The UAE…
Read MoreEnzene Biosciences to expand biosimilar portfolio with the launch of Ranibizumab
INDIA – Enzene Biosciences Limited, the biological arm of Alkem Laboratories, is looking to gain ground in India’s biosimilars market with the launch of its new product Ranibizumab. Enzene Biosciences…
Read More